Journal
CELL STEM CELL
Volume 19, Issue 3, Pages 293-297Publisher
CELL PRESS
DOI: 10.1016/j.stem.2016.08.012
Keywords
-
Categories
Ask authors/readers for more resources
While advanced therapy medicinal products offer great clinical promise, most EU-approved products have not achieved satisfactory commercial performance. Here we highlight a number of issues that prevent current products from obtaining commercial success and pitfalls that developers must overcome in future product development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available